Opportunity, you are correct that Mata Hari is just attempting to claim naked shorting is the explanation for the 6 cent share price. It just is not true. There would be no value shorting this stock at 6 cents because your only hope for profit would the the company going out of business. Moro has enough money to operate for a year so going out of business is not an option for fast profits.
Opportunity, it does indeed cost money to run clinical trials. They are not just some study put together for the ISOBM. The lack of Dog RECAF sales is definitely going to affect the direction the company goes. If RECAF won't sell here, it will not sell in China either. If Dog RECAF won't sell, there is no point in developing a rapid POC for Vet use.
You can see that Moro's direction has now changed to monitoring but again, with no marketing company behind development, it will go nowhere. Moro has some tough decisions to make. With little or no money from revenue, Moro has to make some management decisions. Does he just bide his time conserving money and hope Inverness/Alere does something or does he spend money on trials and hope he will be able to raise more. The last offering was for 7 cents and there is already 166 million shares outstanding.
GoldSeeker™
I have never shorted nor intend to have any financial interest in BOCX. I am not connected with anyone who trades, shorts or has financial interests in BOCX. I only post facts and my opinions. I do not post on IHUB with different aliases.
